Evidence map›Paper›PMID 42440853›Full record

ArticleFrontiers in sports and active living2026

Frequency of intravenous therapy use in elite adult track and field athletes.

Eduard Bezuglov, Evgeny Achkasov, Ryland Morgans, Artemii Lazarev, Oleg Talibov, Elizaveta Kapralova, Elizaveta Koneva, Georgiy Malyakin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eduard BezuglovDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia.
Evgeny AchkasovDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia.
Ryland MorgansDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia.
Artemii LazarevNorthwest Health, Chesterton, Chicago, United States.
Oleg TalibovDepartment of Therapy, Clinical Pharmacology and Ambulance Care, Russian University of Medicine, Moscow, Russia.
Elizaveta KapralovaNational Center of Sports Medicine of Federal Biological Agency, Moscow, Russia.
Elizaveta KonevaDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia.
Georgiy MalyakinDepartment of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the prevalence, patterns and substances of intravenous (IV) therapy among elite endurance athletes. Design: Cross-sectional observational study. Methods: Participants were anonymously surveyed through a specially designed questionnaire. Responses to the questionnaire were received between October 2020 and January 2021. IV use of various medications and its association with sex, age, sporting discipline and competition tier was assessed. Results: Among 138 elite track and field athletes (73 men and 65 women) 56.5% ( Conclusions: The use of IV therapy among elite track and field athletes appears to be relatively common based on self-reported data.

Indexed as

elite athletesinfusionsintravenous dripintravenous fluidsparenteral

Identifiers

PMID42440853
PMCPMC13334425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.